Patients who receive a single "polypill" that combines three common heart medications are more likely to stick to their medication regimens, according to the New York Times. Researchers monitored more than two thousand patients who were prescribed the polypill within six months of a heart attack and found that not only were they more likely to adhere to the simplified medication regimen, they experienced significantly fewer cardiovascular events than patients on a conventional multi-pill regimen. The polypill, which is not yet available in the U.S., combines a blood pressure medication with a cholesterol-lowering drug and aspirin.
One-pill regimen works best for heart patients
